EUVIMEDScopri EUVIMED
Open access · CC BY-NC 4.0

Increased copeptin may reflect vasopressin‐related metabolic changes after bariatric surgery

Francesca Galbiati iD, Imen Becetti, Meghan Lauze, Anna Aulinas, Vibha Singhal iD, Miriam A Bredella, Elizabeth A Lawson, Madhusmita Misra iD

Obesity · 2025

DOI: 10.1002/oby.24200 ↗

At a glance

Journal article in Obesity, 2025. Written by Francesca Galbiati and 7 co-authors. Institution: Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. Major MEDLINE topics: Glycopeptides, Bariatric Surgery, Vasopressins, Obesity. Cited 4 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NCATS NIH HHS, NIMH NIH HHS, NIDDK NIH HHS.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Objective

Mechanisms underlying metabolic improvement following metabolic and bariatric surgery (MBS) may provide insight into novel therapies. Vasopressin improves body composition and protects against hypoglycemia. Associations of copeptin, a stable cleavage product of vasopressin, with BMI and insulin resistance suggest an adaptive increase in vasopressin to counteract metabolic disruption. To our knowledge, no study has investigated copeptin before and after MBS in humans. This study's aim was to investigate copeptin changes following MBS and associations with metabolic parameters.

Methods

This was a 12‐month longitudinal study of 64 youth (78% female; mean age 18.7 [SD 2.8] y) with obesity (mean BMI 45.6 [SD 6.8] kg/m 2 ) undergoing MBS ( n = 34) or nonsurgical (NS) lifestyle management ( n = 30). Fasting copeptin, hemoglobin A1c (HbA1c), homeostatic model assessment for insulin resistance (HOMA‐IR), body composition, and resting energy expenditure (REE) were assessed.

Results

Over 12 months, copeptin increased more (time‐by‐treatment p = 0.017) whereas HbA1c and adiposity decreased more after MBS than NS ( ps ≤ 0.036). Copeptin changes correlated negatively with percentage fat mass and REE changes (rho ≤ −0.29; p s ≤ 0.025) in the whole group, and they correlated positively with HbA1c and HOMA‐IR (rho ≥ 0.41; false discovery rate–adjusted p = 0.05) and negatively with REE changes (rho = −0.55; false discovery rate–adjusted p = 0.036) in the MBS group.

Conclusions

Increases in copeptin after weight loss in MBS compared with NS were associated with lower REE and higher HbA1c/HOMA‐IR values. Vasopressin may contribute to MBS‐related metabolic modifications.

Subjects

MeSH terms (MEDLINE)

GlycopeptidesBariatric SurgeryVasopressinsObesityHumansFemaleGlycated HemoglobinMaleLongitudinal StudiesAdolescentInsulin ResistanceBody CompositionYoung AdultEnergy MetabolismBody Mass IndexAdiposityWeight LossAdult

Substances

GlycopeptidescopeptinsGlycated HemoglobinVasopressinshemoglobin A1c protein, human

Authors and institutions

  • Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Pediatric Endocrinology, Department of Pediatrics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, IR-Sant Pau, Barcelona, Spain.
  • Department of Pediatrics, Mattel Childrens' Hospital, UCLA, Los Angeles, California, USA.
  • Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Radiology, NYU Langone Health and Grossman School of Medicine, New York, New York, USA.

ORCID profiles: Francesca Galbiati, Vibha Singhal, Madhusmita Misra

Funding

  • NCATS NIH HHS
  • NIMH NIH HHS
  • NIDDK NIH HHS
  • NICHD NIH HHS
  • NCRR NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Cite

APA

Galbiati, F., Becetti, I., Lauze, M., Aulinas, A., Singhal, V., Bredella, M. A., Lawson, E. A., & Misra, M. (2025). Increased copeptin may reflect vasopressin‐related metabolic changes after bariatric surgery. Obesity. https://doi.org/10.1002/oby.24200

Vancouver

Galbiati F, Becetti I, Lauze M, Aulinas A, Singhal V, Bredella MA, et al. Increased copeptin may reflect vasopressin‐related metabolic changes after bariatric surgery. Obesity. 2025. doi:10.1002/oby.24200

BibTeX
@article{Galbiati2025,
  author = {Galbiati, Francesca and Becetti, Imen and Lauze, Meghan and Aulinas, Anna and Singhal, Vibha and Bredella, Miriam A and Lawson, Elizabeth A and Misra, Madhusmita},
  title = {Increased copeptin may reflect vasopressin‐related metabolic changes after bariatric surgery},
  journal = {Obesity},
  year = {2025},
  doi = {10.1002/oby.24200}
}
Start for free →